Preferred Label : avatrombopag;
Origin ID : M000597517;
UMLS CUI : C3886460;
Currated CISMeF NLP mapping
- Manual BTNT mappings - CISMeF
- MeSH narrower concept(s)
- Related MeSH concept(s)
- Related record
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3234198/fr/doptelet
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
avatrombopag
avatrombopag
administration, oral
avatrombopag
adult
thrombocytopenia
receptors, thrombopoietin
blood loss, surgical
liver diseases
postoperative hemorrhage
chronic disease
Chronic Liver Disease
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1
each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
avatrombopag
avatrombopag
thiazoles
thiophenes
thiazoles
thiophenes
---
https://www.ema.europa.eu/en/medicines/human/EPAR/doptelet
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
avatrombopag
avatrombopag
avatrombopag
adult
thrombocytopenia
postoperative hemorrhage
administration, oral
receptors, thrombopoietin
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
blood loss, surgical
liver diseases
Chronic Liver Disease
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1
each conventional release oral tablet (clinical drug)
avatrombopag
avatrombopag
thiazoles
thiophenes
thiazoles
thiophenes
---
